LIPANTHYL - FENOFIBRATE FOURNIER - SECALIP
-
Opinions on drugs -
Posted on
Apr 16 2014
Reason for request
Renewal of inclusion
-
Clinical Benefit
Substantial |
The actual benefit of LIPANTHYL, SECALIP and FENOFIBRATE FOURNIER is substantial in the extension of indication " together with a suitable diet and other non-pharmacological treatments (e.g. exercise, weight reduction) in the case of mixed hyperlipidaemia in patients at high cardiovascular risk, in addition to a statin when triglycerides and HDL cholesterol are not adequately controlled." |